CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

Published:2000-10 Issue:10 Volume:14 Page:1259-1266
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Adachi K.,Katsube T.,Kawamura A.,Takashima T.,Yuki M.,Amano K.,Ishihara S.,Fukuda R.,Watanabe M.,Kinoshita Y.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2036.2000.00840.x/fullpdf

Reference47 articles.

1. Optimizing acid suppression for treatment of acid-related diseases;Hunt;Dig Dis Sci,1995

2. Role of gastric acid suppression in the treatment of gastro-oesophageal reflux disease;Bell;Gut,1992

3. Proton pump inhibitors and acid-related diseases;Sachs;Pharmacotherapy,1997

4. Review article: the pharmacology of rabeprazole;Williams;Aliment Pharmacol Ther,1999

5. Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole;Klinkenberg-knol;Aliment Pharmacol Ther,1990

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potassium-competitive acid blocker-associated gastric mucosal lesions;Clinical Endoscopy;2024-07-30

2. Endoscopic findings and outcomes of gastric mucosal changes relating to potassium‐competitive acid blocker and proton pump inhibitor therapy;DEN Open;2024-06-24

3. Helicobacter pylori eradication with high-dose proton pump inhibitor-amoxicillin dual therapy: A systematic review and meta-analysis;International Journal of Antimicrobial Agents;2024-06

4. The presence of hiatal hernia is a significant predictor for symptomatic recurrence after cessation of vonoprazan therapy for gastroesophageal reflux disease: a long-term observational study;Scandinavian Journal of Gastroenterology;2024-05-31

5. Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients;Journal of Gastroenterology and Hepatology;2024-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3